Electromed R&D Spending Growth & History (ELMD)
Electromed's r&d spending was $1.3M for fiscal 2026.
View full Electromed company overviewElectromed annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | $1.3M | $318,000 | +31.93% |
| 2025 | 2025-06-30 | $996,000 | $340,000 | +51.83% |
| 2024 | 2024-06-30 | $656,000 | −$260,000 | −28.38% |
| 2023 | 2023-06-30 | $916,000 | −$440,000 | −32.45% |
| 2022 | 2022-06-30 | $1.4M | −$366,000 | −21.25% |
| 2021 | 2021-06-30 | $1.7M | $672,000 | +64.00% |
| 2020 | 2020-06-30 | $1.1M | $466,689 | +80.01% |
| 2019 | 2019-06-30 | $583,311 | $331,868 | +131.99% |
| 2018 | 2018-06-30 | $251,443 | −$345,433 | −57.87% |
| 2017 | 2017-06-30 | $596,876 | $216,484 | +56.91% |
| 2016 | 2016-06-30 | $380,392 | $64,745 | +20.51% |
| 2015 | 2015-06-30 | $315,647 | −$150,416 | −32.27% |
| 2014 | 2014-06-30 | $466,063 | −$137,312 | −22.76% |
| 2013 | 2013-06-30 | $603,375 | −$317,394 | −34.47% |
| 2012 | 2012-06-30 | $920,769 | −$112,924 | −10.92% |
| 2011 | 2011-06-30 | $1.0M | — | — |
Electromed quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | $328,000 | $26,000 | +8.61% |
| Q3 2026 | 2026-03-31 | $361,000 | $84,000 | +30.32% |
| Q2 2026 | 2025-12-31 | $384,000 | $133,000 | +52.99% |
| Q1 2026 | 2025-09-30 | $241,000 | $75,000 | +45.18% |
| Q4 2025 | 2025-06-30 | $302,000 | $126,000 | +71.59% |
| Q3 2025 | 2025-03-31 | $277,000 | $110,000 | +65.87% |
| Q2 2025 | 2024-12-31 | $251,000 | $144,000 | +134.58% |
| Q1 2025 | 2024-09-30 | $166,000 | −$40,000 | −19.42% |
| Q4 2024 | 2024-06-30 | $176,000 | −$122,000 | −40.94% |
| Q3 2024 | 2024-03-31 | $167,000 | $1,000 | +0.60% |
| Q2 2024 | 2023-12-31 | $107,000 | −$47,000 | −30.52% |
| Q1 2024 | 2023-09-30 | $206,000 | −$92,000 | −30.87% |
| Q4 2023 | 2023-06-30 | $298,000 | −$17,000 | −5.40% |
| Q3 2023 | 2023-03-31 | $166,000 | −$170,000 | −50.60% |
| Q2 2023 | 2022-12-31 | $154,000 | −$175,000 | −53.19% |
| Q1 2023 | 2022-09-30 | $298,000 | −$78,000 | −20.74% |
| Q4 2022 | 2022-06-30 | $315,000 | −$12,000 | −3.67% |
| Q3 2022 | 2022-03-31 | $336,000 | −$71,000 | −17.44% |
| Q2 2022 | 2021-12-31 | $329,000 | −$178,000 | −35.11% |
| Q1 2022 | 2021-09-30 | $376,000 | −$105,000 | −21.83% |
| Q4 2021 | 2021-06-30 | $327,000 | −$88,624 | −21.32% |
| Q3 2021 | 2021-03-31 | $407,000 | $15,038 | +3.84% |
| Q2 2021 | 2020-12-31 | $507,000 | $363,523 | +253.37% |
| Q1 2021 | 2020-09-30 | $481,000 | $382,063 | +386.17% |
| Q4 2020 | 2020-06-30 | $415,624 | $309,098 | +290.16% |
| Q3 2020 | 2020-03-31 | $391,962 | $221,205 | +129.54% |
| Q2 2020 | 2019-12-31 | $143,477 | −$94,361 | −39.67% |
| Q1 2020 | 2019-09-30 | $98,937 | $30,747 | +45.09% |
| Q4 2019 | 2019-06-30 | $106,526 | $25,205 | +30.99% |
| Q3 2019 | 2019-03-31 | $170,757 | $128,092 | +300.23% |
| Q2 2019 | 2018-12-31 | $237,838 | $181,044 | +318.77% |
| Q1 2019 | 2018-09-30 | $68,190 | −$2,473 | −3.50% |
| Q4 2018 | 2018-06-30 | $81,321 | $16,699 | +25.84% |
| Q3 2018 | 2018-03-31 | $42,665 | −$37,948 | −47.07% |
| Q2 2018 | 2017-12-31 | $56,794 | −$44,007 | −43.66% |
| Q1 2018 | 2017-09-30 | $70,663 | −$280,177 | −79.86% |
| Q4 2017 | 2017-06-30 | $64,622 | −$132,727 | −67.25% |
| Q3 2017 | 2017-03-31 | $80,613 | −$3,797 | −4.50% |
| Q2 2017 | 2016-12-31 | $100,801 | $43,711 | +76.57% |
| Q1 2017 | 2016-09-30 | $350,840 | $309,297 | +744.52% |
| Q4 2016 | 2016-06-30 | $197,349 | $118,902 | +151.57% |
| Q3 2016 | 2016-03-31 | $84,410 | $6,118 | +7.81% |
| Q2 2016 | 2015-12-31 | $57,090 | −$26,553 | −31.75% |
| Q1 2016 | 2015-09-30 | $41,543 | −$33,722 | −44.80% |
| Q4 2015 | 2015-06-30 | $78,447 | $17,393 | +28.49% |
| Q3 2015 | 2015-03-31 | $78,292 | −$24,874 | −24.11% |
| Q2 2015 | 2014-12-31 | $83,643 | −$9,092 | −9.80% |
| Q1 2015 | 2014-09-30 | $75,265 | −$133,843 | −64.01% |
| Q4 2014 | 2014-06-30 | $61,054 | −$230,422 | −79.05% |
| Q3 2014 | 2014-03-31 | $103,166 | $1,706 | +1.68% |
| Q2 2014 | 2013-12-31 | $92,735 | −$16,515 | −15.12% |
| Q1 2014 | 2013-09-30 | $209,108 | $107,919 | +106.65% |
| Q4 2013 | 2013-06-30 | $291,476 | $76,361 | +35.50% |
| Q3 2013 | 2013-03-31 | $101,460 | −$136,770 | −57.41% |
| Q2 2013 | 2012-12-31 | $109,250 | −$141,089 | −56.36% |
| Q1 2013 | 2012-09-30 | $101,189 | −$115,896 | −53.39% |
| Q4 2012 | 2012-06-30 | $215,115 | −$129,219 | −37.53% |
| Q3 2012 | 2012-03-31 | $238,230 | −$34,040 | −12.50% |
| Q2 2012 | 2011-12-31 | $250,339 | $31,636 | +14.47% |
| Q1 2012 | 2011-09-30 | $217,085 | $18,699 | +9.43% |
| Q4 2011 | 2011-06-30 | $344,334 | — | — |
| Q3 2011 | 2011-03-31 | $272,270 | — | — |
| Q2 2011 | 2010-12-31 | $218,703 | — | — |
| Q1 2011 | 2010-09-30 | $198,386 | — | — |
Electromed r&d spending trends
Over the last five fiscal years, Electromed's r&d spending decreased from $1.7M to $1.3M, a change of −$408,000. The latest reported quarter, Q4 2026, shows $328,000.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Electromed source filings ↗